老年人2型糖尿病与肌少症的关系研究进展

doi:10.3969/j.issn.1003-9198.2024.05.023

摘要/Abstract

摘要： 肌少症现已被认为是一种独立疾病,其诊断标准由肌肉质量、肌肉力量与功能三方面构成,作为老年人衰弱的基本特征,肌少症常与多种慢性疾病共存。糖尿病是老年人常见慢性病之一,血糖控制水平、血糖波动范围对糖尿病进展影响深远。近年研究发现,糖尿病与肌少症存在氧化应激、炎症反应、胰岛素抵抗、线粒体功能障碍和细胞自噬等多种共同机制。同时,血糖水平在肌少症和糖尿病之间发挥关键作用并促进两种疾病的发生发展,进而对病人预后造成不利影响,本文拟对糖尿病与肌少症的关系进一步深入阐述。

关键词: 肌少症, 2型糖尿病, 血糖水平, 老年人

中图分类号:

王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.

参考文献

[1] LIVSHITS G, KALINKOVICH A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis [J]. Ageing Res Rev, 2019, 56:100980.
[2] JACKMAN R W, KANDARIAN S C. The molecular basis of skeletal muscle atrophy [J]. Am J Physiol, 2004, 287(4): 834-843.
[3] SEMBA R D, NICKLETT E J, FERRUCCI L. Does accumulation of advanced glycation end products contribute to the aging phenotype? [J]. J Gerontol A Biol Sci Med Sci, 2010, 65(9): 963-975.
[4] TABARA Y, IKEZOE T, YAMANAKA M, et al. Advanced glycation end product accumulation is associated with low skeletal muscle mass, weak muscle strength, and reduced bone density: the Nagahama study [J]. J Gerontol A Biol Sci Med Sci, 2019, 74(9): 1446-1453.
[5] POLYZOS S A, KOUNTOURAS J, MANTZOROS C S. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics [J]. Metabolism, 2019, 92:82-97.
[6] HALIM M, HALIM A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes) [J]. Diabetol, 2019, 13(2): 1165-1172.
[7] COSENTINO F, HÜRLIMANN D, DELLI GATTI C, et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia [J]. Heart, 2008, 94(4): 487-492.
[8] UMEGAKI H. Sarcopenia and frailty in older patients with diabetes mellitus [J]. Geriatr Gerontol Int, 2016, 16(3): 293-299.
[9] VILLALOBOS-LABRA R, SUBIABRE M, TOLEDO F, et al. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity [J]. Mol Aspects Med, 2019, 66:49-61.
[10] PARK M H, KIM D H, LEE E K, et al. Age-related inflammation and insulin resistance: a review of their intricate interdependency [J]. Arch Pharm Res, 2014, 37(12): 1507-1514.
[11] KALINKOVICH A, LIVSHITS G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis [J]. Ageing Res Rev, 2017, 35:200-221.
[12] ALEMÁN-MATEO H, LÓPEZ TEROS M T, RAMÍREZ F A, et al. Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants [J]. J Gerontol A Biol Sci Med Sci, 2014, 69(7): 871-877.
[13] GLANCY B, HARTNELL L M, MALIDE D, et al. Mitochondrial reticulum for cellular energy distribution in muscle [J]. Nature, 2015, 523(7562): 617-620.
[14] SHENOUDA S M, WIDLANSKY M E, CHEN K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus [J]. Circulation, 2011, 124(4): 444-453.
[15] PHIELIX E, SCHRAUWEN-HINDERLING V B, MENSINK M, et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients [J]. Diabetes, 2008, 57(11): 2943-2949.
[16] BAJPEYI S, PASARICA M, MORO C, et al. Skeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes [J]. J Clin Endocrinol Metab, 2011, 96(4): 1160-1168.
[17] RITOV V B, MENSHIKOVA E V, AZUMA K, et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity [J]. Am J Physiol Endocrinol Metab, 2010, 298(1): 49-58.
[18] GAN Z, FU T, KELLY D P, et al. Skeletal muscle mitochondrial remodeling in exercise and diseases [J]. Cell Res, 2018, 28(10): 969-980.
[19] CHOI A M K, RYTER S W, LEVINE B. Autophagy in human health and disease [J]. N Engl J Med, 2013, 368(7): 651-662.
[20] LI X, HE S, MA B. Autophagy and autophagy-related proteins in cancer [J]. Mol Cancer, 2020, 19(1): 12.
[21] EBATO C, UCHIDA T, ARAKAWA M, et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet [J]. Cell Metab, 2008, 8(4): 325-332.
[22] CARNIO S, LOVERSO F, BARAIBAR M A, et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging [J]. Cell Rep, 2014, 8(5): 1509-1521.
[23] MLLER A B, KAMPMANN U, HEDEGAARD J, et al. Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes [J]. Sci Rep, 2017, 7:43775.
[24] JI J, PETROPAVLOVSKAIA M, KHATCHADOURIAN A, et al. Type 2 diabetes is associated with suppression of autophagy and lipid accumulation in β-cells [J]. J Cell Mol Med, 2019, 23(4):2890-2900.
[25] AAS S N, HAMARSLAND H, CUMMING K T, et al. The impact of age and frailty on skeletal muscle autophagy markers and specific strength: a cross-sectional comparison [J]. Exp Gerontol, 2019, 125:110687.
[26] MANCINI G B J, MARON D J, HARTIGAN P M, et al. Lifestyle, glycosylated hemoglobin A1c, and survival among patients with stable ischemic heart disease and diabetes [J]. J Am Coll Cardiol, 2019, 73(16): 2049-2058.
[27] SEFEROVIC P M, POLOVINA M. In search of a ‘safety zone’ for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease [J]. Eur J Heart Fail, 2020, 22(11): 2035-2037.
[28] SUGIMOTO K, IKEGAMI H, TAKATA Y, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: The MUSCLES-DM Study [J]. J Am Med Dir Assoc, 2021, 22(4):834-838.
[29] BERETTA M V, DANTAS FILHO F F, FREIBERG R E, et al. Sarcopenia and type 2 diabetes mellitus as predictors of 2-year mortality after hospital discharge in a cohort of hospitalized older adults [J]. Diabetes Res Clin Pr, 2020, 159:107969
[30] KENG B M H, GAO F, TEO L L Y, et al. Associations between skeletal muscle and myocardium in aging: a syndrome of “cardio-sarcopenia”? [J]. J Am Geriatr Soc, 2019, 67(12): 2568-2573.
[31] HAN P, ZHAO J, GUO Q, et al. Incidence, risk factors, and the protective effect of high body mass index against sarcopenia in suburb-dwelling elderly Chinese populations [J]. J Nutr Health Aging, 2016, 20(10): 1056-1060.
[32] HAN P, KANG L, GUO Q, et al. Prevalence and factors associated with sarcopenia in suburb-dwelling older Chinese using the Asian Working Group for sarcopenia definition [J]. J Gerontol A Biol Sci Med Sci, 2016, 71(4): 529-535.
[33] KIM K S, PARK K S, KIM M J, et al. Type 2 diabetes is associated with low muscle mass in older adults [J]. Geriatr Gerontol Int, 2014, 14:115-121.
[34] PARASOGLOU P, RAO S, SLADE J M. Declining skeletal muscle function in diabetic peripheral neuropathy [J]. Clin Ther, 2017, 39(6): 1085-1103.
[35] BAUER J, MORLEY J E, SCHOLS A M W J, et al. Sarcopenia: a time for action. An SCWD Position Paper [J]. J Cachexia Sarcopeni, 2019, 10(5): 956-961.
[36] HOFBAUER L C, BUSSE B, EASTELL R, et al. Bone fragility in diabetes: novel concepts and clinical implications [J]. Lancet Diabetes Endo, 2022, 10(3): 207-220.
[37] GANZ D A, LATHAM N K. Prevention of falls in community-dwelling older adults [J]. New Engl J Med, 2020, 382(8): 734-743.
[38] TAKAHASHI F, HASHIMOTO Y, KAJI A, et al. Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus [J]. Front Endocrinol, 2021, 12:783363.